52
Participants
Start Date
September 12, 2022
Primary Completion Date
May 31, 2023
Study Completion Date
July 31, 2023
Magnesium Sulfate, Heptahydrate
A single dose of intravenous magnesium sulfate given over 20 minutes through a peripheral intravenous line. Two arms of the study will deliver intravenous magnesium, one at a dose of 50 mg/kg, and the other at a dose of 75 mg/kg.
0.9% saline
A single dose of intravenous 0.9% sodium chloride given over 20 minutes through a peripheral intravenous line as the placebo arm of the study.
Children's Hospital of Philadelphia, Philadelphia
Nationwide Children's Hospital, Columbus
Primary Children's Hospital, Salt Lake City
Children's Hospital of Philadelphia
OTHER
Nationwide Children's Hospital
OTHER
National Heart, Lung, and Blood Institute (NHLBI)
NIH
University of Utah
OTHER